No Data
Trendlines Updates Portfolio Milestones and Equity Incentive Moves
Trendlines' Phytolon Raises US$23.6 Million to Scale Natural Food Colors After FDA Nod
Trendlines Portfolio Company Closes $24 Million Series B Financing
Trendlines Group's ElastiMed Expands Medical Wearables to US Market; Shares Drop 2%
Trendlines, Controlling Shareholder to Invest Combined $1.4 Million in Portfolio Firms
The Trendlines Drug Secures US FDA Nod for Phase 2 Bladder Treatment Trial; Shares Surge 5%